UCSF DIABETES, ENDOCRINOLOGY & METABOLISM TRAINING PROGRAM FACULTY RESEARCH SUMMARIES

I am involved in several large epidemiologic studies of osteoporosis and women's health and direct multicenter trials in the prevention of fractures. These studies include the Study of Osteoporotic Fractures, the Osteoporosis in Men (Mr. OS) study, and the Multiple Outcomes of Raloxifene Evaluation (MORE) trial. We are currently pursuing research about the hormonal determinants of risk of breast cancer. Current major areas of investigation are in women's health, aging, prevention, clinical trials and research methods. Specific areas of work include epidemiology of osteoporosis and fractures, estrogen therapy, selective estrogen receptor modulators, and breast cancer.

Selected References

Nevitt MC, Cummings SR, Stone KL, Palermo L, Black DM, Bauer DC, Genant HK, Hochberg MC, Ensrud KE, Hillier TA, Cauley JA. Risk factors for a first-incident radiographic vertebral fracture in women > or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res. 2005 Jan;20(1):131-40.

Schwartz AV, Sellmeyer DE, Strotmeyer ES, Tylavsky FA, Feingold KR, Resnick HE, Shorr RI, Nevitt MC, Black DM, Cauley JA, Cummings SR, Harris TB; Health ABC Study. Diabetes and bone loss at the hip in older black and white adults. J Bone Miner Res. 2005 Apr;20(4):596-603.

Cauley JA, Lui LY, Ensrud KE, Zmuda JM, Stone KL, Hochberg MC, Cumming SR. Bone mineral density and the risk of incident nonspinal fractures in black and white women. JAMA. 2005 May 4;293(17):2102-8.

Siris ES, Harris ST, Eastell R, Zanchetta JR, Goemaere S, Diez-Perez A, Stock JL, Song J, Qu Y, Kulkarni PM, Siddhanti SR, Wong M, Cummings SR; for the Continuing Outcomes Relevant to Evista (CORE) Investigators. Skeletal Effects of Raloxifene After 8 Years: Results from the Continuing Outcomes Relevant to Evista (CORE) Study. J Bone Miner Res. 2005 Sep;20(9):1514-24.

back to faculty list